Medical News Today Thu, 19 Jul 2007 1:18 AM PDT
The Multiple Sclerosis Society of Canada announced a 2.4 million dollars grant to continue a closely-watched clinical trial involving an experimental bone marrow stem cell transplant therapy. The trial is being conducted by a team of Canadian MS specialists led by Dr. Mark Freedman and Dr. Harry Atkins in Ottawa. [click link for full article]
Powered Wheelchair Provision "Unacceptable", UK
Medical News Today Thu, 19 Jul 2007 1:18 AM PDT
The MS Society is extremely concerned that people with multiple sclerosis (MS) across Devon have to wait years to receive the powered wheelchair they so desperately need and is backing the intervention of Teign MP, Richard Younger-Ross. MS can have a severe impact on mobility and wheelchairs can be an essential part of maintaining a person's independence and wellbeing. [click link for full ...
MS Society Frustrated Over Unemployed Physios, UK
Medical News Today Thu, 19 Jul 2007 1:18 AM PDT
The MS Society has condemned news that 1,500 recently qualified physiotherapists are unable to find permanent work - despite huge demand for specialist physiotherapy services for people with multiple sclerosis (MS). Chief executive Simon Gillespie said: "There is clear evidence that specialist physiotherapy can help people with MS manage their symptoms more effectively. [click link for full ...
When MS Attacks
WebMD Wed, 18 Jul 2007 10:56 AM PDT
Here's the latest on fighting flare-ups of multiple sclerosis.
MS Society announces $2.4 M for stem cell research
CBC Wed, 18 Jul 2007 2:57 PM PDT
Two Ottawa researchers will continue work on bone marrow stem cell transplant therapy for people with multiple sclerosis thanks to a new $2.4 million grant.
Canada Adult Stem Cell Research Program Gets $2 Million Grant from MS Society
Ottawa, Canada (LifeNews.com) -- Because It has had positive results with adult stem cell research, the Ottawa Health Research Institute at the University of Ottawa will receive a $2.4 million grant over five years to continue the research. The funds come from the Multiple Sclerosis Society of Canada which announced the award yesterday that will help the institute's bone marrow stem cell transplant therapy trial it began in October 2000. The research involves using a patient's own bone marrow cells to replace a diseased immune system with a new purified one. The procedure has shown positive results in cancer patients but hasn't been tried thoroughly in patients with autoimmune diseases. More than two dozen patients were initially selected for the trials and 18 have received the transplant therapy. Although one patient died early on, the procedure was modified and now most of the patients who have had the adult bone marrow cell transplants have seen their conditions stabilize or improve. Several have had significant unexpected improvements. "The hope was that treatment would stabilize progression of the disease, but researchers have found that some patients have experienced improved vision and improved walking ability," Ottawa Health Research Institute spokeswoman Jennifer Paterson told the Ottawa Sun newspaper. "Part of this money will go to finding out what is causing that tissue repair. Additional funds will go to transplants for six more patients."
0 Comments:
Post a Comment
<< Home